GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET FORECAST 2019-2028

The global extra corporeal membrane oxygenation (ECMO) system market is projected to register a CAGR of 4.74% between 2019 and 2028, and is anticipated to generate revenue of $450.0 million by 2028.

Extra Corporeal Membrane Oxygenation (ECMO) System is an extracorporeal method of providing prolonged respiratory and cardiac provision to persons whose lungs and heart are unable to deliver an acceptable amount of gas perfusion or exchange to sustain life.

global-extra-corporeal-membrane-oxygenation-system-market

To know more about this report, request a free sample copy

Key factors propelling the global extra corporeal membrane oxygenation (ECMO) system market growth are:

  • Increased usage of ECMO technology
  • Technological advancement
  • Growing burden of chronic disorders
    • According to the World Health Organization (WHO), cardiovascular disease is the leading cause of death all around the world. It was recorded that approximately 17.9 million people died due to cardiovascular diseases globally, in 2016
    • Furthermore, chronic obstructive pulmonary disease (COPD) is a respiratory condition, wherein the patient experiences breathlessness due to the constriction of alveoli, the tiny air sacs of the lungs that allow rapid gaseous exchange.

Major restraining factors:

  • Lack of specialized expertise
  • High cost of ECMO system
  • Side effects related to the ECMO system
    • The ECMO system that is used in pregnancy and the postpartum period is often associated with complications, such as maternal and fetal bleeding.
    • Such complications can further increase the risk of morbidity, and severe complications have been observed when the ECMO technology is used after extracorporeal cardiopulmonary resuscitation.
  • Presence of conventional techniques

The report scope of the global extra corporeal membrane oxygenation (ECMO) system market analysis includes the segmentation analysis of modality and application. These segments are further classified to provide a detailed analysis of the studied market.

Market by Application:

  • Respiratory
    • The respiratory category dominated the application segment. It is also set to record the highest CAGR. Acute respiratory distress syndrome (ARDS) is one of the most analyzed indications for ECMO therapy. ARDS is a life-menacing disorder. It is caused by diffuse alveolar damage and capillary endothelial injury. It results in poor oxygenation and non-compliant lungs.
  • Cardiac
  • Extracorporeal cardiopulmonary resuscitation (ECPR)

Geographically, the global extra corporeal membrane oxygenation (ECMO) system market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America dominated the global market in 2019. Cardiovascular disease (CVD) was the leading cause of death in the United States in 2016, as per the CDC. As per the Centers for Disease Control and Prevention (CDC), about 5.7 million adults in the United States die of heart failure every year. This is anticipated to drive the market growth during the forecast period.
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Asia Pacific: India, Australia & New Zealand, China, South Korea, Japan, Thailand, Indonesia, Vietnam, and Rest of Asia Pacific
    • The Asia Pacific is set to record the fastest CAGR. The major factors contributing to the growth of the extra corporeal membrane oxygenation (ECMO) system market in the APAC region includes the growing prevalence of chronic diseases, such as cardiopulmonary diseases, due to unhealthy eating habits and excess tobacco consumption.
    • As per the OECD report, tobacco smoking is a chief risk factor for six of the eight foremost causes (cerebrovascular disease, ischemic heart disease, chronic obstructive pulmonary disease, lower respiratory infections, cancer of the trachea, bronchus and lung and tuberculosis) of premature death.
  • Rest of World: Latin America, the Middle East & Africa

The major market players in the global extra corporeal membrane oxygenation (ECMO) system market are:

  • Abbott Laboratories
  • Getinge AB
  • Medtronic PLC
  • Microport Scientific Corporation
  • Terumo Medical Corporation
  • Others

Key strategies adopted by some of the extra corporeal membrane oxygenation (ECMO) system companies:

In February 2020, Eurosets announced the usages of its CO2Reset device for the first time to treat a hypercapnic patient at the Erasme University Hospital in Brussels. CO2Reset is a novel medium-stream ECCO2R innovation, with a devoted oxygenator and circuit which are completely PC-covered and approved for utilization around five days.

Key findings of the global extra corporeal membrane oxygenation (ECMO) system market:

  • There is a growing cognizance towards the application of ECMO.
  • Veno-venous is the highest revenue-generating modality segment.
  • Respiratory is the fastest-growing application.
  • The emergence of new technology is beneficial to market growth.

Frequently Asked Questions & Answers (FAQ):

  • What is the revenue generated by the Asia Pacific Market?

      A: As of 2019, the Asia Pacific generated a revenue of $69.1 million.

  • What type of patients are treated with ECMO system?

    A: ECMO therapy is intended for patients whose heart and lungs cannot function normally, without external support.

  • Which is the major factor affecting market growth?

      A: The high cost of the ECMO system is one of the major factors that could affect the market revenue.

  • How intense is the competition among the companies in the market?

   A: The industry rivalry is anticipated to rise over the forecast period owing to new product development, modification in the current products of the ECMO system, and implementation of price reduction strategies.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. MARKET DEFINITION
    2.    KEY DRIVERS
      1. INCREASED USAGE OF ECMO TECHNOLOGY
      2. TECHNOLOGICAL ADVANCEMENT
      3. GROWING BURDEN OF CHRONIC DISORDERS
    3.    KEY RESTRAINTS
      1. LACK OF SPECIALIZED EXPERTISE
      2. HIGH COST OF ECMO SYSTEM
      3. SIDE EFFECTS RELATED TO THE ECMO SYSTEM
      4. PRESENCE OF CONVENTIONAL TECHNIQUES
  4. KEY ANALYTICS
    1.    PORTER’S FIVE FORCE ANALYSIS
      1. THREAT OF NEW ENTRY
      2. THREAT OF SUBSTITUTION
      3. BUYER’S POWER
      4. SUPPLIER’S POWER
      5. COMPETITIVE RIVALRY
    2. IMPACT OF COVID-19 ON ECMO SYSTEM MARKET
    3. OPPORTUNITY MATRIX
    4. VENDOR LANDSCAPE
    5. KEY INVESTMENT INSIGHTS
  5. MARKET BY MODALITY
    1. VENO-VENOUS
    2. VENO-ARTERIAL
    3. OTHER MODALITIES
  6. MARKET BY APPLICATION
    1. RESPIRATORY
    2. CARDIAC
    3. EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
  7. GEOGRAPHICAL ANALYSIS
    1.    NORTH AMERICA
      1. THE UNITED STATES
      2. CANADA
    2.    EUROPE
      1. THE UNITED KINGDOM
      2. GERMANY
      3. FRANCE
      4. ITALY
      5. RUSSIA
      6. BELGIUM
      7. POLAND
      8. REST OF EUROPE
    3.    ASIA PACIFIC
      1. CHINA
      2. JAPAN
      3. INDIA
      4. AUSTRALIA & NEW ZEALAND
      5. SOUTH KOREA
      6. THAILAND
      7. INDONESIA
      8. VIETNAM
      9. REST OF ASIA PACIFIC
    4.    REST OF WORLD
      1. LATIN AMERICA
      2. MIDDLE EAST & AFRICA
  8. COMPANY PROFILES
    1. ABBOTT LABORATORIES
    2. ALUNG TECHNOLOGIES INC
    3. ELSIUS BIOMEDICAL INC
    4. EUROSETS
    5. GETINGE AB
    6. LIVANOVA PLC
    7. MEDTRONIC PLC
    8. MICROPORT SCIENTIFIC CORPORATION
    9. NIPRO CORPORATION
    10. ORIGEN BIOMEDICAL INC
    11. SPECTRUM MEDICAL
    12. TERUMO MEDICAL CORPORATION
    13. XENIOS AG (FRESENIUS SE & CO KGAA)
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM

TABLE 2: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 4: GLOBAL VENO-VENOUS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: GLOBAL VENO-VENOUS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 6: GLOBAL VENO-ARTERIAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: GLOBAL VENO-ARTERIAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 8: GLOBAL OTHER MODALITIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: GLOBAL OTHER MODALITIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 10: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 11: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 12: GLOBAL RESPIRATORY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 13: GLOBAL RESPIRATORY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 14: GLOBAL CARDIAC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 15: GLOBAL CARDIAC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 16: GLOBAL EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 17: GLOBAL EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 18: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 19: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION MARKET, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 20: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 21: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 22: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 23: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 24: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 25: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 26: REST OF WORLD EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 27: REST OF WORLD EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: LIST OF CHRONIC DISEASES

FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: KEY INVESTMENT INSIGHTS

FIGURE 6: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, IN 2019

FIGURE 7: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-VENOUS, 2019-2028 (IN $ MILLION)

FIGURE 8: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-ARTERIAL, 2019-2028 (IN $ MILLION)

FIGURE 9: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY OTHER MODALITIES, 2019-2028 (IN $ MILLION)

FIGURE 10: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, IN 2019

FIGURE 11: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY RESPIRATORY, 2019-2028 (IN $ MILLION)

FIGURE 12: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY CARDIAC, 2019-2028 (IN $ MILLION)

FIGURE 13: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR), 2019-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 15: THE UNITED STATES EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 16: CANADA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 17: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 18: THE UNITED KINGDOM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 19: GERMANY EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 20: FRANCE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 21: ITALY EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 22: RUSSIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 23: BELGIUM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 24: POLAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 25: REST OF EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 26: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 27: CHINA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 28: JAPAN EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 29: INDIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 30: AUSTRALIA & NEW ZEALAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 31: SOUTH KOREA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 32: THAILAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 33: INDONESIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 34: VIETNAM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 35: REST OF ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 36: REST OF WORLD EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 37: LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 38: MIDDLE EAST & AFRICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

Request For A Free Sample